Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea · Delayed Price · Currency is KRW 7,730.00
+210.00 (2.79%)
At close: Apr 24, 2026
KOSDAQ:318160 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8,721 | 4,379 | -1,857 | 2,890 | 3,131 |
Depreciation & Amortization | 2,434 | 1,906 | 1,803 | 1,861 | 1,539 |
Loss (Gain) From Sale of Assets | -181.58 | -12.55 | 218.15 | 19.17 | 63.68 |
Asset Writedown & Restructuring Costs | - | - | 372.86 | - | 308.07 |
Loss (Gain) From Sale of Investments | -6.81 | -5 | -10.2 | - | 1,500 |
Stock-Based Compensation | - | - | - | - | 141.91 |
Provision & Write-off of Bad Debts | 409.38 | -37.26 | 326.36 | 87.8 | 417.06 |
Other Operating Activities | -186.75 | -1,487 | 3,527 | -748.18 | 842.36 |
Change in Accounts Receivable | -5,799 | 339.63 | -1,526 | 1,136 | 1,140 |
Change in Inventory | -7,523 | 4,384 | 344.4 | -2,516 | -3,192 |
Change in Accounts Payable | 1,631 | 1,586 | 202.36 | -1,590 | 3.93 |
Change in Other Net Operating Assets | 1,988 | -1,782 | -1,641 | -701.9 | 1,719 |
Operating Cash Flow | 1,487 | 9,271 | 1,759 | 437.8 | 7,614 |
Operating Cash Flow Growth | -83.96% | 426.97% | 301.84% | -94.25% | 104.51% |
Capital Expenditures | -6,638 | -2,024 | -627.84 | -360.31 | -3,725 |
Sale of Property, Plant & Equipment | 1,240 | 116.58 | 26.74 | 32.5 | 71.05 |
Cash Acquisitions | - | - | 11,488 | - | - |
Divestitures | 163.05 | - | - | - | 202 |
Sale (Purchase) of Intangibles | -170.75 | -1.99 | -504.87 | -14.63 | -124.48 |
Investment in Securities | 9,446 | -2,159 | -7,402 | 5,033 | -1,072 |
Other Investing Activities | -169.32 | -567.52 | -351 | -671.19 | 112.98 |
Investing Cash Flow | 3,801 | -4,643 | 2,630 | 4,020 | -4,535 |
Short-Term Debt Issued | 3,259 | 3,675 | 1,387 | 5,342 | 4,535 |
Long-Term Debt Issued | 9,500 | - | - | - | - |
Total Debt Issued | 12,759 | 3,675 | 1,387 | 5,342 | 4,535 |
Short-Term Debt Repaid | -3,133 | -6,332 | - | -5,008 | - |
Long-Term Debt Repaid | -255 | -165.97 | -6,182 | -14,234 | -217.48 |
Total Debt Repaid | -3,388 | -6,498 | -6,182 | -19,242 | -217.48 |
Net Debt Issued (Repaid) | 9,372 | -2,823 | -4,795 | -13,900 | 4,317 |
Issuance of Common Stock | 364.96 | - | - | - | - |
Repurchase of Common Stock | -2,197 | -2,796 | -37.25 | - | - |
Other Financing Activities | 7.3 | -5 | - | 5 | - |
Financing Cash Flow | 7,547 | -5,623 | -4,832 | -13,895 | 4,317 |
Foreign Exchange Rate Adjustments | -16.71 | 42.6 | 0.58 | 3.59 | 280.38 |
Net Cash Flow | 12,818 | -953.01 | -442.28 | -9,434 | 7,676 |
Free Cash Flow | -5,151 | 7,247 | 1,131 | 77.49 | 3,889 |
Free Cash Flow Growth | - | 540.50% | 1360.05% | -98.01% | - |
Free Cash Flow Margin | -10.09% | 25.50% | 4.14% | 0.28% | 11.06% |
Free Cash Flow Per Share | -627.58 | 812.26 | 133.91 | 11.07 | 492.62 |
Cash Interest Paid | 180.07 | 920.98 | 913.78 | 494.66 | 315.16 |
Cash Income Tax Paid | 745.9 | 791 | 809.63 | 2,074 | 428.79 |
Levered Free Cash Flow | -10,997 | 5,630 | 2,010 | -1,015 | 2,592 |
Unlevered Free Cash Flow | -10,798 | 5,887 | 2,315 | -730.29 | 2,975 |
Change in Working Capital | -9,703 | 4,528 | -2,621 | -3,672 | -329.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.